Lower fasting total plasma homocysteine levels in stable renal transplant recipients versus maintenance dialysis patients

被引：7

作者：

Bostom, AG

Shemin, D

Gohh, RY

Verhoef, P

Nadeau, MR

Bianchi, LA

Hopkins-Garcia, BJ

Jacques, PF

Selhub, J

Dworkin, L

Rosenberg, IH

机构：

[1] Tufts Univ, USDA, Vitamin Bioavailabil Lab, Jean Mayer Human Nutr Res Ctr Aging, Boston, MA 02111 USA

[2] Rhode Isl Hosp, Div Renal Dis & Transplant Serv, Providence, RI USA

[3] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA

[4] Agr Univ Wageningen, Wageningen, Netherlands

来源：

TRANSPLANTATION PROCEEDINGS | 1998年 / 30卷 / 01期

关键词：

D O I：

10.1016/S0041-1345(97)01219-0

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：160 / 162

页数：3

共 34 条

[1] Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients [J].

Arnadottir, M ;

Hultberg, B ;

Vladov, V ;

NilssonEhle, P ;

Thysell, H .

TRANSPLANTATION, 1996, 61 (03) :509-512

[2]

BACHMANN J, 1995, J AM SOC NEPHROL, V6, P121

[3] NET UPTAKE OF PLASMA HOMOCYSTEINE BY THE RAT-KIDNEY IN-VIVO [J].

BOSTOM, A ;

BROSNAN, JT ;

HALL, B ;

NADEAU, MR ;

SELHUB, J .

ATHEROSCLEROSIS, 1995, 116 (01) :59-62

[4] Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients [J].

Bostom, AG ;

Shemin, D ;

Lapane, KL ;

Nadeau, MR ;

Sutherland, P ;

Chan, J ;

Rozen, R ;

Yoburn, D ;

Jacques, PF ;

Selhub, J ;

Rosenberg, IH .

ATHEROSCLEROSIS, 1996, 123 (1-2) :193-202

[5] High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients [J].

Bostom, AG ;

Shemin, D ;

Lapane, KL ;

Hume, AL ;

Yoburn, D ;

Nadeau, MR ;

Bendich, A ;

Selhub, J ;

Rosenberg, IH .

KIDNEY INTERNATIONAL, 1996, 49 (01) :147-152

[6] Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients - A prospective study [J].

Bostom, AG ;

Shemin, D ;

Verhoef, P ;

Nadeau, MR ;

Jacques, PF ;

Selhub, J ;

Dworkin, L ;

Rosenberg, IH .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2554-2558

[7] HYPERHOMOCYSTEINEMIA AND TRADITIONAL CARDIOVASCULAR-DISEASE RISK-FACTORS IN END-STAGE RENAL-DISEASE PATIENTS ON DIALYSIS - A CASE-CONTROL STUDY [J].

BOSTOM, AG ;

SHEMIN, D ;

LAPANE, KL ;

MILLER, JW ;

SUTHERLAND, P ;

NADEAU, M ;

SEYOUM, E ;

HARTMAN, W ;

PRIOR, R ;

WILSON, PWF ;

SELHUB, J .

ATHEROSCLEROSIS, 1995, 114 (01) :93-103

[8] Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients [J].

Bostom, AG ;

Gohh, RY ;

Tsai, MY ;

HopkinsGarcia, BJ ;

Nadeau, MR ;

Bianchi, LA ;

Jacques, PF ;

Rosenberg, IH ;

Selhub, J .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) :1894-1900

[9] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].

BOUSHEY, CJ ;

BERESFORD, SAA ;

OMENN, GS ;

MOTULSKY, AG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057

[10] HOMOCYSTEINE AND CYSTEINE - DETERMINANTS OF PLASMA-LEVELS IN MIDDLE-AGED AND ELDERLY SUBJECTS [J].

BRATTSTROM, L ;

LINDGREN, A ;

ISRAELSSON, B ;

ANDERSSON, A ;

HULTBERG, B .

JOURNAL OF INTERNAL MEDICINE, 1994, 236 (06) :633-641

← 1 2 3 4 →